B-Raf-Mutated Melanoma

Until fairly recently, treatment options for advanced melanoma have been relatively limited. Fortunately, the last decade has seen dramatic improvements in response rates and duration of overall survival after the introduction of checkpoint inhibitors and targeted therapies against mutations in the...

Full description

Saved in:
Bibliographic Details
Main Authors: Fenton, Sarah E. (Author), Sosman, Jeffrey A. (Author), Chandra, Sunandana (Author)
Format: Ebooks
Published: IntechOpen, 2020-04-27.
Subjects:
Online Access:Get Online
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 01501 am a22002173u 4500
001 intechopen_books_7866
042 |a dc 
100 1 0 |a Fenton, Sarah E.  |e author 
700 1 0 |a Sosman, Jeffrey A.  |e author 
700 1 0 |a Chandra, Sunandana  |e author 
245 0 0 |a B-Raf-Mutated Melanoma 
260 |b IntechOpen,   |c 2020-04-27. 
500 |a https://mts.intechopen.com/articles/show/title/b-raf-mutated-melanoma 
520 |a Until fairly recently, treatment options for advanced melanoma have been relatively limited. Fortunately, the last decade has seen dramatic improvements in response rates and duration of overall survival after the introduction of checkpoint inhibitors and targeted therapies against mutations in the B-isoform of Raf (B-Raf) in metastatic or inoperable melanoma. This book chapter will discuss the role of wild type B-Raf in the cell, the changes induced by mutations in this protein, and current FDA approvals for targeted therapies against B-Raf, both as a monotherapy and in combination with MEK inhibitors. We will also summarize mechanisms of resistance against these targeted therapies as well as novel therapeutic regimens proposed to bypass resistance. 
540 |a https://creativecommons.org/licenses/by/3.0/ 
546 |a en 
690 |a Cutaneous Melanoma 
655 7 |a Chapter, Part Of Book  |2 local 
786 0 |n https://www.intechopen.com/books/7866 
787 0 |n ISBN:978-1-78984-139-8 
856 \ \ |u https://mts.intechopen.com/articles/show/title/b-raf-mutated-melanoma  |z Get Online